{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:04:32Z","timestamp":1789761872873,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.07.013","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:09:03Z","timestamp":1786626543000},"page":"575-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biopsy Gleason pattern 4 burden refines preoperative risk stratification in prostate cancer"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0893-7473","authenticated-orcid":false,"given":"Theodoros","family":"Karanikolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Tripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aboumohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilir","family":"Agalliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.07.013_bib0001","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.juro.2009.08.026","article-title":"Prostate cancer-specific mortality and Gleason 7 disease: differences in outcomes between Gleason 4+3 and Gleason 3+4 tumours in a population-based cohort","volume":"182","author":"Wright","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0002","series-title":"EAU\u2013EANM\u2013ESTRO\u2013ESUR\u2013ISUP\u2013SIOG guidelines on prostate cancer","author":"Cornford","year":"2025"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0003","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology consensus conference on Gleason grading of prostatic carcinoma","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0004","doi-asserted-by":"crossref","DOI":"10.1097\/JU9.0000000000000299","article-title":"Biopsy Gleason pattern 4 length as a predictor for T3 disease and lymph node metastasis","volume":"3","author":"Sandoval","year":"2025","journal-title":"JU Open Plus"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0005","first-page":"211","article-title":"Association of absolute amount of pattern 4 disease on prostate biopsy with oncologic outcomes in intermediate-risk prostate cancer: a systematic review","volume":"19","author":"Soon","year":"2025","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.juro.2018.07.062","article-title":"Clinical usefulness of total length of Gleason pattern 4 on biopsy in men with grade Group 2 prostate cancer","volume":"201","author":"Dean","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0007","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JU.0000000000002685","article-title":"Oncologic outcomes of total length Gleason pattern 4 on biopsy in men with grade Group 2 prostate cancer","volume":"208","author":"Perera","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0008","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/bco2.195","article-title":"Highest percentage of Gleason pattern 4 predicts outcome in intermediate-risk prostate cancer","volume":"4","author":"Sato","year":"2023","journal-title":"BJUI Compass"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ajcp\/aqad005","article-title":"Significance of percentage of Gleason pattern 4 at prostate biopsy in predicting adverse pathology at radical prostatectomy","volume":"160","author":"Ordner","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0010","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/bju.16884","article-title":"Quantification of gleason pattern 4 to predict oncologic outcomes","volume":"136","author":"Olivier","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euros.2022.04.011","article-title":"Risk estimation of metastatic recurrence after prostatectomy using preoperative MRI and targeted biopsy","volume":"41","author":"Bommelaere","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0012","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.euros.2025.01.012","article-title":"Confirmatory biopsy outcomes in patients with grade Group 2 prostate cancer","volume":"72","author":"Leni","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0013","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology for translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0014","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","article-title":"The UCSF cancer of the Prostate Risk Assessment Score","volume":"173","author":"Cooperberg","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.urology.2022.08.014","article-title":"Blood prostate-specific antigen by volume of benign and malignant prostate tissue","volume":"170","author":"Andolfi","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2024.01.005","article-title":"Amount of Gleason pattern 3 is not predictive of risk in grade group 2\u20134 prostate cancer","volume":"86","author":"Vickers","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0017","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/JU.0000000000004484","article-title":"Absolute volume of Gleason pattern 4 at radical prostatectomy predicts advanced stage and biochemical recurrence","volume":"213","author":"Scuderi","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0018","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00428-022-03301-y","article-title":"Alternative prostate cancer grading systems incorporating percent pattern 4\/5 and cribriform architecture","volume":"480","author":"Seyrek","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.anndiagpath.2015.10.013","article-title":"Outcomes of Gleason score 3+4 prostate cancer with minimal versus higher pattern 4 on biopsy","volume":"20","author":"K\u0131r","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0020","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/PAS.0000000000000235","article-title":"Gleason score 3+4 prostate cancer with minimal pattern 4 on biopsy predicts low-risk disease","volume":"38","author":"Huang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2016.07.076","article-title":"Limitations in predicting organ-confined prostate cancer in men with Gleason pattern 4 on biopsy","volume":"197","author":"Perlis","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0022","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/his.14590","article-title":"Cribriform architecture outperforms percent pattern 4 in grade group 2 prostate cancer","volume":"80","author":"Seyrek","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0023","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2020.02.004","article-title":"Gleason pattern 4 with cribriform morphology on biopsy predicts adverse pathology","volume":"98","author":"Haffner","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2026.07.013_bib0024","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5152\/tud.2023.23076","article-title":"Distinct outcomes of small versus large cribriform patterns in Gleason 7 prostate cancer","volume":"49","author":"Kazan","year":"2023","journal-title":"Urol Res Pract"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:13:19Z","timestamp":1789758799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926006095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926006095"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.013","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biopsy Gleason pattern 4 burden refines preoperative risk stratification in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}